Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion type Assertion NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_head.
- NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_provenance.
- NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion evidence source_evidence_literature NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_provenance.
- NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion SIO_000772 25349966 NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_provenance.
- NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion wasDerivedFrom befree-20150227 NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_provenance.
- NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_assertion wasGeneratedBy ECO_0000203 NP624639.RAfYH2Nl9LoxBd3v1gesj_AhQnt246PVpOp3XEg8Dp2fs130_provenance.